Extracellular vesicle-mediated delivery of anti-miR-106b inhibits morphine-induced primary ciliogenesis in the brain

Rong Ma1, Naseer A Kutchy2, Zhongbin Wang3

  • 1Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.

Insights

Extracellular vesicles (EVs) from morphine-exposed astrocytes drive primary ciliogenesis, a key factor in morphine tolerance. Inhibiting this process with anti-miR-106b delivered via EVs offers a potential therapeutic strategy for opioid use disorder.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Opioid use disorder (OUD) arises from cellular changes in the brain due to repeated opioid use.
  • Extracellular vesicle (EV)-induced primary ciliogenesis is implicated in morphine tolerance.
  • Understanding the mechanisms of EV-mediated primary ciliogenesis is crucial for developing OUD treatments.

Purpose of the Study:

  • To investigate the mechanisms by which astrocyte-derived EVs mediate morphine-induced primary ciliogenesis.
  • To explore the therapeutic potential of targeting this pathway using EV-mediated delivery of small RNAs.

Main Methods:

  • Analysis of miRNA cargo in morphine-stimulated astrocyte-derived EVs (morphine-ADEVs).
  • Investigating the role of miR-106b and its target CEP97 in primary ciliogenesis.
  • Intranasal delivery of anti-miR-106b-loaded ADEVs in morphine-administered mice.
  • Confirmation of primary ciliogenesis in astrocytes from opioid abusers.

Main Results:

  • Morphine-ADEVs contain miRNA cargo that induces primary ciliogenesis in astrocytes.
  • miR-106b-5p within morphine-ADEVs targets CEP97, promoting primary ciliogenesis.
  • Intranasal delivery of anti-miR-106b-loaded ADEVs reduced miR-106b, inhibited ciliogenesis, and prevented morphine tolerance.
  • Primary ciliogenesis was observed in astrocytes of individuals with opioid abuse.

Conclusions:

  • miR-106b-5p in morphine-ADEVs mediates morphine-induced primary ciliogenesis by targeting CEP97.
  • EV-mediated delivery of anti-miR-106b is a promising therapeutic strategy to prevent morphine tolerance and OUD.
  • This study provides novel insights into primary cilium-mediated OUD mechanisms.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
311
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
268